City

Clinical trials near Graz, Austria

Active studies with a listed research site in Graz, Austria.

15active studies

11recruiting now

12countries represented

563largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver DiseaseCondition

Tirzepatide, RetatrutideTreatment

Argentina, Australia563 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07165028See eligibility →

Recruiting nowPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium187 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937086See eligibility →

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowPhase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated SteatohepatitisCondition

Survodutide, Placebo matching survodutideTreatment

Argentina, Australia445 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT06632457See eligibility →

Recruiting nowPhase 3

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Obesity, Type 2 DiabetesCondition

Cagrisema, SemaglutideTreatment

Argentina, Australia303 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07564414See eligibility →

Recruiting nowPhase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver FibrosisCondition

Survodutide, PlaceboTreatment

Argentina, Australia528 locations

Boehringer IngelheimSponsor

Updated 2026-08-21 · NCT06632444See eligibility →

Recruiting nowNot applicable

Pregnancy Cohort Study: Pregnancy as a Window to Future Health

Healthy Pregnant Women, Obese Pregnant WomenCondition

Intervention not listedTreatment

Austria1 locations

Medical University of GrazSponsor

Updated 2026-04-13 · NCT06925815See eligibility →

Recruiting nowNot applicable

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

Obesity & Overweight, Circadian Rhythm DisordersCondition

Verum (A), Placebo (B)Treatment

Austria1 locations

FH Joanneum Gesellschaft mbHSponsor

Updated 2026-02-27 · NCT07440147See eligibility →

Recruiting nowNot applicable

Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort

Obesity, AgingCondition

comprehensive metabolic phenotypingTreatment

Austria2 locations

Thomas SchererSponsor

Updated 2026-02-17 · NCT06511297See eligibility →

Recruiting nowNot applicable

Josef Ressel Centre Perinatal Programming

Childhood ObesityCondition

observationTreatment

Austria1 locations

Moenie van der KleynSponsor

Updated 2025-03-17 · NCT03634930See eligibility →

Recruiting nowNot applicable

ESAN II - Energy Sensing in Depression

Immune System Tolerance, DepressionCondition

Aronia Juice, PlaceboTreatment

Austria1 locations

Medical University of GrazSponsor

Updated 2024-11-27 · NCT05432362See eligibility →

Active, not recruitingPhase 3

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic SteatohepatitisCondition

Semaglutide, PlaceboTreatment

Argentina, Australia558 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT04822181See eligibility →

Active, not recruitingPhase 1, Phase 2

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Overweight and ObesityCondition

AZD9550, placeboTreatment

Austria, Canada15 locations

AstraZenecaSponsor

Updated 2026-08-26 · NCT06151964See eligibility →

Active, not recruitingNot applicable

Cardiovascular and InflammAging Study

Aging, Cardiovascular DiseasesCondition

Juice Plus+ Fruit, Vegetable and Berry blends, Juice Plus+ Omega blendTreatment

Austria2 locations

Green BeatSponsor

Updated 2025-07-01 · NCT04763291See eligibility →

Active, not recruitingNot applicable

ESAN III - Energy Sensing in Depression

Obesity, Gut Microbiota ModulationCondition

Carotenoid-rich juice, ControlTreatment

Austria1 locations

Medical University of GrazSponsor

Updated 2025-06-27 · NCT06985381See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Graz, Austria

Current studies

Related cities